VMP 42016211000001108

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Pentazocine 25mg tablets
BNF code 0407020T0AAABAB
Virtual Therapeutic Moiety Pentazocine
Date identifier became valid 3 Jul 2023
Previous product identifier 322601004
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Pentazocine hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 25.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category Schedule 3 (CD No Register Exempt Safe Custody)
Date of applicability 24 Nov 2014
Previous Controlled Drug information Schedule 3 (CD No Register)
Actual Medicinal Products
Pentazocine 25mg tablets (A A H Pharmaceuticals Ltd)
Pentazocine 25mg tablets (Accord-UK Ltd)
Pentazocine 25mg tablets (Alliance Healthcare (Distribution) Ltd)
Pentazocine 25mg tablets (Medihealth (Northern) Ltd)
Pentazocine 25mg tablets (Phoenix Healthcare Distribution Ltd)
Pentazocine 25mg tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Pentazocine 25mg tablets 100 tablet
Pentazocine 25mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback